P53/MDM2 Complex-Based Targeted Strategies in Colon Adenocarcinoma

Athanasios Niotis, Evangelos Tsiambas, Dimitrios Dimitroulis, Helen Sarlanis, Evangelos Falidas, Nikolaos Kavantzas, Constantinos A. Constantinides


In the current molecular review, we describe the mechanisms of TP53/MDM2 deregulation and their impact on the colon adenocarcinoma molecular substrate and phenotype. Among the genes that are critically altered in carcinogenesis, the TP53 tumor suppressor gene is of major importance. The TP53 gene (gene locus: 17p13.1) regulates the cell cycle by controlling the G1/S and G2/M checkpoints securing the normal sequence of cell cycle phases. Furthermore, it is involved in apoptosis programmed cell death. The gene is mutated or epigenetically altered in all epithelial malignancies, including colon adenocarcinoma. Additionally, Mouse Double Minute 2 Homolog (MDM2), a proto-oncogene (12q14.3), acts as a major negative regulator for p53 expression in the p53-MDM2 auto-regulatory pathway. MDM2 binds directly to p53 and represses its transcriptional activity, promoting p53 degradation.

Conclusion. In colon adenocarcinoma, MDM2 oncogene overexpression directly influences p53 oncoprotein expression levels.


Colon; Carcinoma; p53-MDM2; Immunohistochemistry; Genetics

Full Text:


DOI: http://dx.doi.org/10.5644/ama2006-124.398


  • There are currently no refbacks.

2023 Department of Medical Sciences, Academy of Sciences and Arts of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina. All rights reserved.
The full text of articles published in this journal can be used free of charge for personal and educational purposes while respecting authors and publishers’ copyrights. For commercial purposes no part of this journal may be reproduced without the written permission of the publisher.